Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Imagin Medical's share price for the quarter that ended in Mar. 2023 was $0.1434. Imagin Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 10.83 Mil. Therefore, Imagin Medical's market cap for the quarter that ended in Mar. 2023 was $1.55 Mil.
Imagin Medical's quarterly market cap
declined
from Sep. 2022 ($2.17 Mil) to Dec. 2022 ($2.12 Mil) and
declined
from Dec. 2022 ($2.12 Mil) to Mar. 2023 ($1.55 Mil).
Imagin Medical's annual market cap
declined
from Sep. 2020 ($3.46 Mil) to Sep. 2021 ($3.43 Mil) and
declined
from Sep. 2021 ($3.43 Mil) to Sep. 2022 ($2.17 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Imagin Medical's Enterprise Value for Today is $0.00 Mil.
Imagin Medical Market Cap Historical Data
The historical data trend for Imagin Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Imagin Medical's Market Cap
For the Medical Devices subindustry, Imagin Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imagin Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Imagin Medical's Market Cap falls into.
Imagin Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Imagin Medical's Market Cap for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imagin Medical (OTCPK:IMEXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Imagin Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Imagin Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Imagin Medical (Imagin Medical) Business Description
Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMEXF has been successfully added to your 